Effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) on neutrophil kinetics and function in normal human volunteers
Authors:
- 1 January 1998
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 57 (1) , 7-15
Abstract
Granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) (250 μg/m2) was administered subcutaneously to 7 normal volunteers for up to 14 days to study its effects on neutrophil kinetics and function. With treatment, blood neutrophil counts rose gradually to peak at 3½ times baseline by day 14. At day 5 marrow mitotic cells were increased and post‐mitotic cells decreased, and the transit time through the post‐mitotic marrow pool accelerated (normal = 6.4 days, GM‐CSF = 3.9 days; P < 0.01). Treatment had little effect on the blood neutrophil half‐life (normal = 9.6 ± 1.3 hours; GM‐CSF = 13.1 ± 2.4 hours, P > 0.05); or the neutrophil turnover rate (normal = 78.5 ± 11.9 × 107/cells/kg/day, GM‐CSF = 91.4 ± 19.8 × 107/cells/kg/day, P > 0.05). GM‐CSF reduced the number of neutrophils migrating to skin chambers (normal = 104 ± 25.0 × 106/cells, GM‐CSF = 48.6 ± 16.0 × 106/cells; P < 0.05). Treatment increased expression of CD11b/CD18 but not Fcγ receptors (CD16, CD32, CD64). Treatment also stimulated the in vitro neutrophil respiratory burst in response to a variety of agonists, and this enhancement persisted for the duration of treatment. All subjects experienced local and systemic adverse effects and developed eosinophilia. This study indicates that GM‐CSF at a dose of 250 μg/m2 causes neutrophilia chiefly by accelerating delivery of neutrophils from the marrow to the blood and by decreasing migration from the blood to the tissues, with only a modest effect on neutrophil production and blood half‐life. Am. J. Hematol. 57:7–15, 1998.Keywords
This publication has 38 references indexed in Scilit:
- Cell cycle kinetics of hematopoiesis before and after in vivo administration of GM-CSF in refractory anemia: Evidence for a shortening of the granulocyte release timeAnnals of Hematology, 1994
- Different membrane expression of CD11b and CD 14 on blood neutrophils following in vivo administration of myeloid growth factorsBritish Journal of Haematology, 1993
- Prevention and treatment of staphylococcus aureus infections with recombinant cytokinesCytokine, 1993
- Haemopoietic cell kinetics in humans treated with rGM‐CSFInternational Journal of Cancer, 1992
- Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor.Journal of Clinical Investigation, 1989
- Effect of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor on Myelopoiesis in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1987
- Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival.Journal of Clinical Investigation, 1986
- Comparison of 3H-Diisopropyl Fluorophosphate and 32P-Diisopropyl Fluorophosphate for Neutrophil Kinetic StudiesActa Haematologica, 1982
- Comparison of agents producing a neutrophilic leukocytosis in man. Hydrocortisone, prednisone, endotoxin, and etiocholanolone.Journal of Clinical Investigation, 1975
- LEUKOKINETIC STUDIES. IV. THE TOTAL BLOOD, CIRCULATING AND MARGINAL GRANULOCYTE POOLS AND THE GRANULOCYTE TURNOVER RATE IN NORMAL SUBJECTS*Journal of Clinical Investigation, 1961